Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study
T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America)
Source: International Congress 2019 – New towards old therapies in airway diseases
Session: New towards old therapies in airway diseases
Session type: Oral Presentation
Number: 2104
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America). Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study. 2104
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: